Volume 30, 2019
Proceedings of the Thirtieth Annual Meeting
William P. Smith, Barrie E. Litzky
Crossing the Shareholder-First Border
The Case of Trek Therapeutics
This project investigates critical issues and events related to Trek Therapeutics experience as a public benefit corporation. We will present and discuss how Trek differentiates itself in an industry where the attention is on high prices supporting high investor returns. Trek’s benefit corporation status helped it garner favorable attention in some respects, but has also presented challenges, particularly when it comes to attracting new capital.